Search
Kamada Ltd
KMDAAdd to Watchlist
7.500USD
-0.020-0.27%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
432.65MMarket Cap
21.41P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.27%
5 Days
+3.31%
1 Month
+1.63%
6 Months
+6.69%
Year to Date
+6.23%
1 Year
-4.82%
Key Figures
7.540Open
7.605High
17.98KVolume
21.41P/E TTM
12.11P/E Dynamic
0.188Dividend TTM
0.03%Turnover Ratio
7.520Prev. Close
7.460Low
104.98KTurnover
29.92P/E Static
1.67P/B
2.50%Div Yield TTM
5.37%ROA
9.35052wk High
0.78Volume Ratio
14.46MNet Profit
57.69MShares
0.3504EPS TTM
0.87Beta
7.97%ROE
6.50052wk Low
1.93%Amplitude
42.25%Gross Margin
432.65MMarket Cap
1.30Reward/Risk
1.46%Risk Rate
TradingKey Stock Score of Kamada Ltd
Currency: USD Updated: 2026-07-02Key Insights
Kamada Ltd's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 70 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Kamada Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Kamada Ltd Highlights
StrengthsRisks
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.62% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 180.46M.
Fairly Valued
The company’s latest PE is 21.41, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 28.17M shares, decreasing 7.11% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 3.03K shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
13.000
Target Price
+72.87%
Upside Space
Kamada Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Kamada Ltd Info
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Ticker SymbolKMDA
CompanyKamada Ltd
CEOLondon (Amir)
Websitehttps://www.kamada.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Kamada Ltd (KMDA)?
The current price of Kamada Ltd (KMDA) is 7.50.
What is the symbol of Kamada Ltd?
The ticker symbol of Kamada Ltd is KMDA.
What is the 52-week high of Kamada Ltd?
The 52-week high of Kamada Ltd is 9.35.
What is the 52-week low of Kamada Ltd?
The 52-week low of Kamada Ltd is 6.50.
What is the market capitalization of Kamada Ltd?
The market capitalization of Kamada Ltd is 432.65M.
Is Kamada Ltd (KMDA) currently rated as Buy, Hold, or Sell?
According to analysts, Kamada Ltd (KMDA) has an overall rating of Buy, with a price target of 13.00.
What is the Earnings Per Share (EPS TTM) of Kamada Ltd (KMDA)?
The Earnings Per Share (EPS TTM) of Kamada Ltd (KMDA) is 0.35.